...$105.6 million) Shares: 20.6 million Price: €3.81 Shares after offering: 41.3 million Underwriters: Piper Jaffray; WestLB...

...by shareholder dievini Hopp BioTech. dievini Hopp now holds 59% of Agennix. Piper Jaffray and WestLB...

...Talactoferrin is a recombinant human lactoferrin (rhLF) dendritic cell recruiter and activator. Piper Jaffray and WestLB...

...raised: Up to €78.4 million ($100.5 million) Shares: 20.6 million Price: €3.81 Underwriters: Piper Jaffray; WestLB...

...not subscribed or sold in the private placement to purchase in shares. Piper Jaffray and WestLB...

...Alta Berkeley Associates; Alta Partners; Domain Associates; IKB; Julius Baer; Merlin Biosciences; Techno-Venture; Viscardi GmbH; WestLB...
...Alta Berkeley Associates; Alta Partners; Life Science Venture Fund; Merlin Biosciences; TVM Capital; Viscardi GmbH; WestLB...

...proposed EUR 13.80-EUR 15.80 range and values the company at EUR 165 million ($209.8 million). WestLB...

...59.2 million ($75.3 million) and have a post-money valuation of EUR 177 million ($225.1 million). WestLB...

...million ($66.4-$78.2 million). Deutsche Bank acted as global coordinator and lead manager, while Piper Jaffray; WestLB...

...Nov. 3. Deutsche Bank is global coordinator and lead manager. Other underwriters include Piper Jaffray; WestLB...